AMSTTechnology · Software - ApplicationAMST Stock Forecast: Amesite, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 40 of 100 as at 22 Aug 2026 — in the lower half.
AMST stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Amesite, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Growth (99): Sales and profits are climbing, and climbing faster than before.
Value (12): The shares cost a lot relative to the profits and assets behind them.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
AMST stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on AMST, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AMST appears on the weeks it earns a place.
AMST vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 24 Aug 2026, Amesite, Inc. returned −56.9% against +19.6% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
AMST analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Amesite, Inc. (AMST) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- −1.0×
- Price / sales
- 20.5×
- Price / book
- 3.9×
- EV / EBITDA
- −1.9×
Cheaper than 82% of US stocks
Cheaper than 9% of US stocks
Cheaper than 28% of US stocks
Cheaper than 71% of US stocks
- Revenue growth (YoY)
- 171.5%
- Earnings growth (YoY)
- 171.5%
- Gross margin
- —
- Operating margin
- −820.9%
- Net margin
- 0.0%
Higher than 96% of US stocks
Higher than 89% of US stocks
Higher than 6% of US stocks
Higher than 30% of US stocks
- Return on equity
- −121.5%
- Return on assets
- −69.5%
- Dividend yield
- —
Higher than 11% of US stocks
Higher than 5% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
Amesite, Inc. (AMST) statistics: revenue, profit & scale
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Amesite, Inc. has a market value of $7.0M and an enterprise value of $5.6M.
Revenue in the twelve months to 31 Mar 2026: $341K. The latest quarter grew 171.5% year on year.
Net income over the same four quarters: −$3.0M, a −871.9% net margin.
Free cash flow in the twelve months to 31 Mar 2026: −$2.2M, after $293K of capital spending.
Trailing P/E: −1.0×.
Amesite, Inc. employs 6 people — $57K of revenue per employee.
Data provided by Twelve Data
AMST vs competitors
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Amesite, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about AMST stock
How does Ticker Nerd's model rank AMST?
As at 22 Aug 2026, Amesite, Inc. ranks 40 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (99 of 100).
What is the AMST stock forecast for 2030?
No analyst covering Amesite, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AMST are extrapolating price history, which says nothing about the business.
How has AMST stock performed over the past year?
Amesite, Inc. returned -56.9% over the 12 months to 24 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Amesite, Inc. do?
Amesite Inc. is a technology company that develops and markets B2C and B2B AI-driven applications, primarily focused on the healthcare sector.
About Amesite, Inc.
Amesite Inc. is a technology company that develops and markets B2C and B2B AI-driven applications, primarily focused on the healthcare sector. Its flagship product, NurseMagic, is a mobile app that streamlines documentation for nurses and caregivers, enhances patient communication, provides technical assistance, and supports navigation of workplace challenges, all while ensuring HIPAA compliance through proprietary AI trained on industry-specific data. NurseMagic integrates seamlessly into healthcare workflows, offers translations in over 50 languages, and serves users across more than 100 professions in all 50 states and 21 countries. The company also provides Amesite Engage, a platform leveraging AI infrastructure for professional skill-building applications tailored to individual and enterprise needs. Operating in the SaaS industry within the technology sector, Amesite Inc. targets home healthcare and broader care segments, improving operational efficiency, care quality, and professional support. Founded in 2017 and headquartered in Detroit, Michigan, Amesite Inc. delivers secure, scalable AI solutions for healthcare professionals and businesses.
CEO Dr. Ann Marie Sastry Ph.D. · 6 employees · United States · https://www.amesite.com